About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Melanoma Clinical Trials | 3,339 Studies Recruiting

Clinical TrialsMelanoma

Melanoma Clinical Trials

Browse 3,339 clinical trials for melanoma. Find studies that match your criteria and connect with research centers.

Find trials near:

New York Los Angeles Chicago Houston Phoenix Philadelphia

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 21-40 of 3,339 trials

TerminatedPhase I/II Trial of Valproic Acid and Karenitecin for MelanomaThis is a Phase I study looking at the combination of Valproic Acid (VPA) and Karenitecin to treat patients with metastatic malignant melanoma.NCT00358319·Tampa, Florida Active not recruitingA Study of TSR-022 in Participants With Advanced Solid Tumors (AMBER)This is a first-in-human study evaluating the anti-T cell immunoglobulin and mucin containing protein-3 (TIM-3) antibody TSR-022.NCT02817633·Goodyear, Arizona and 88 others

Related Searches

skin cancertrials

Data from ClinicalTrials.govTerms

TerminatedChemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Metastatic MelanomaRATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.NCT00003552·Bethesda, Maryland

CompletedA Study of IMMray™ PanCan-d Test for Early Detection of Pancreatic Cancer in High-risk GroupsPanFAM-1 is a clinical study for early detection of pancreatic cancer in high-risk groups.NCT03693378·Stanford, California and 20 others

CompletedIntratumoral Injection of IP-001 Following Thermal Ablation in Patients With Advanced Solid Tumors.The therapeutic approach taken by trial SAKK 66/17 is different from those already used in clinical practice and possibly offers patients a therapeutic benefit after failure of…NCT03993678·Bern and 2 others

WithdrawnSafety and Efficacy of Intramuscular Electrotransfer of Plasmid AMEP in Patients Suffering From Advanced or Metastatic MelanomaThe objective of the present trial is: * to determine the dose limiting toxicity (DLT), maximal tolerated dose (MTD) and recommended phase 2 dose (RP2D) of intramuscular…NCT01764009·Le Kremlin-Bicêtre and 3 others

CompletedPrognostic and Treatment-Response Factors in Metastatic Melanoma: Multi-Center AnalysisThis multicenter, retrospective observational study aims to identify clinical, pathological, and molecular factors associated with prognosis and treatment response in patients…NCT07256184·Ankara, Yenimahalle and 1 other

WithdrawnA Platform Study of Novel Immunotherapy Products in Participants With Previously Treated Unresectable or Metastatic Cutaneous MelanomaThis is a platform study evaluating the safety and efficacy of multiple novel investigational products (IPs) that target unresectable or metastatic cutaneous melanoma in…NCT05572463·San Francisco, California and 12 others

WithdrawnRO4929097 in Treating Patients With Stage IIIB, Stage IIIC, or Stage IV Melanoma That Can Be Removed by SurgeryThis pilot phase II trial is studying how well RO4929097 works in treating patients with stage III, or stage IV melanoma that can be removed by surgery.NCT01216787·New York, New York and 1 other

Active not recruitingC7R-GD2.CART Cells for Patients With Relapsed or Refractory Neuroblastoma and Other GD2 Positive Cancers (GAIL-N)This study is for patients with neuroblastoma, sarcoma, uveal melanoma, breast cancer, or another cancer that expresses a substance on the cancer cells called GD2.NCT03635632·Houston, Texas and 1 other

CompletedInterest of the 18F-DOPA-PET Imaging in Metastatic Melanoma Treated With B-RAF Inhibitors: a Pilot StudyMelanoma incidence is increasing in most developed countries. At the metastatic stage, the prognosis is usually poor.NCT02038348·Marseille

CompletedVaccine Therapy Plus Interleukin-2 With or Without Interferon Alfa-2b in Treating Patients With Stage III MelanomaRATIONALE: Vaccines may make the body build an immune response and kill tumor cells. Interleukin-2 may stimulate a person's white blood cells to kill tumor cells.NCT00004104·New York, New York

CompletedCarboplatin and Paclitaxel With or Without Sorafenib Tosylate in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed by SurgeryThis randomized phase III trial studies carboplatin, paclitaxel, and sorafenib tosylate to see how well they work compared to carboplatin and paclitaxel in treating patients with…NCT00110019·Birmingham, Alabama and 218 others

CompletedVaccination With 6MHP, With or Without Systemic CDX-1127, in Patients With Stage II-IV MelanomaThis study evaluates whether it is safe to administer a peptide vaccine (6MHP) with adjuvants and the CDX-1127 monoclonal antibody, and whether the adjuvants and the CDX-1127…NCT03617328·Charlottesville, Virginia and 1 other

CompletedRadiation, Chemotherapy, Vaccine and Anti-MART-1 and Anti-gp100 Cells for Patients With Metastatic MelanomaBackground: * Melanoma antigen recognized by T-cells (MART-1) and gp100 are two genes found in melanoma cells.NCT00923195·Bethesda, Maryland

CompletedPhase 2 Study of Ipilimumab Plus Dacarbazine in Japanese Patients With Advanced MelanomaThe purpose of this study is to determine the survival rate after 1 year of treatment with ipilimumab plus dacarbazine in patients with previously untreated Stage III…NCT01681212·Fukuoka, Fukuoka and 5 others

CompletedInterest of Tumor Replicates in Avian Embryo to Model Therapeutic Effects of BRAFi/MEKi in BRAF Mutated MelanomaThis is an interventional mono-centric study in patients with BRAF mutated metastatic melanoma treated with BRAF/MEK inhibitors.NCT04039672·Pierre-Bénite

CompletedRetrospective Analysis of Response Markers and Adverse Events in Melanoma Patients Treated With PembrolizumabThis study is a retrospective cohort study.NCT02600169·Groningen

UnknownSafety and Efficacy of Recombinant Oncolytic Adenovirus L-IFN Injection in Relapsed/Refractory Solid Tumors Clinical StudyThis is an open-label, dose escalation study of the safety and tolerability of Recombinant oncolytic adenovirus L-IFN injection（YSCH-01） when administered via intratumoral…NCT05180851·Shanghai, Shanghai Municipality

CompletedSkin Health Online for Melanoma: Better Risk AssessmentThis study will have two phases, with an added usability test after Phase I and before Phase 2. Phase 1: Cognitive Interviews of materials in Spanish.NCT03130569·Albuquerque, New Mexico

PreviousPage 2 of 167Next